- Home
- SWAG vs BIAF Comparison
SWAG vs BIAF Comparison
Compare SWAG & BIAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SWAG
- BIAF
- Stock Information
- Founded
- SWAG 1994
- BIAF 2014
- Country
- SWAG United States
- BIAF United States
- Employees
- SWAG N/A
- BIAF N/A
- Industry
- SWAG Advertising
- BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- SWAG Consumer Discretionary
- BIAF Health Care
- Exchange
- SWAG Nasdaq
- BIAF Nasdaq
- Market Cap
- SWAG 20.2M
- BIAF 21.4M
- IPO Year
- SWAG 2021
- BIAF 2022
- Fundamental
- Price
- SWAG $1.18
- BIAF $1.25
- Analyst Decision
- SWAG
- BIAF Strong Buy
- Analyst Count
- SWAG 0
- BIAF 1
- Target Price
- SWAG N/A
- BIAF $6.00
- AVG Volume (30 Days)
- SWAG 12.3K
- BIAF 220.8K
- Earning Date
- SWAG 11-26-2024
- BIAF 11-14-2024
- Dividend Yield
- SWAG N/A
- BIAF N/A
- EPS Growth
- SWAG N/A
- BIAF N/A
- EPS
- SWAG 0.00
- BIAF N/A
- Revenue
- SWAG $75,893,871.00
- BIAF $7,315,883.00
- Revenue This Year
- SWAG $11.55
- BIAF $302.41
- Revenue Next Year
- SWAG N/A
- BIAF $15.00
- P/E Ratio
- SWAG $599.76
- BIAF N/A
- Revenue Growth
- SWAG 28.74
- BIAF 30185.99
- 52 Week Low
- SWAG $1.02
- BIAF $1.21
- 52 Week High
- SWAG $1.74
- BIAF $3.62
- Technical
- Relative Strength Index (RSI)
- SWAG 56.70
- BIAF 34.94
- Support Level
- SWAG $1.10
- BIAF $1.30
- Resistance Level
- SWAG $1.19
- BIAF $1.37
- Average True Range (ATR)
- SWAG 0.04
- BIAF 0.07
- MACD
- SWAG 0.01
- BIAF -0.00
- Stochastic Oscillator
- SWAG 78.50
- BIAF 0.00
About SWAG Stran & Company Inc.
Stran & Co Inc is an outsourced marketing solutions provider, working closely with customers to develop sophisticated marketing programs that leverage promotional products and loyalty incentive expertise. In addition to selling branded products, It offer its clients with custom sourcing capabilities which is a flexible and customizable e-commerce solution for promoting branded merchandise and other promotional products, managing promotional loyalty and incentives, print collateral, and event assets, order and inventory management, and designing and hosting online retail popup shops. The company purchases products and branding through various third-party manufacturers and decorators and resells the finished goods to customers.
About BIAF bioAffinity Technologies Inc.
bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.